entertainment -WSS

entertainment

author：leisure time 2025-10-01 10:52:58 - browse：8758

Sammy Kimball for STAT

What can Homer teach us about biotech? Has Big Science gotten too big? And what’s the future of treating Alzheimer’s disease?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Neil Kumar, CEO of BridgeBio, joins us to talk about how his small company came to develop what could be a big drug — and why classical Greek literature remains relevant. We also discuss the latest news in the life sciences, including the abrupt resignation of the celebrity scientist who led Stanford University and the implications of tornado damage at a Pfizer plant.

For more on what we cover, here’s the news on BridgeBio; here’s more on the Stanford president; here’s the latest on the Pfizer plant; here’s the story on Eli Lilly’s Alzheimer’s data; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Synthetic human embryos? Researchers say term is overblown

WSS

Merck, Daiichi strike cancer drug pact worth up to $22 billion

FDA clears Verve to begin U.S. study of gene

Roche drug slashes death risk in early

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

FDA clears Verve to begin U.S. study of gene

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Wikipedia

entertainment

entertainment

What does generative AI mean for health care? We asked experts

Illumina to lay off 10% of research and development team

Virginia high school admissions case could be legal follow

STAT Summit: The economic case for universal basic health care

Psychedelics group wrestles with new pharma identity

GOP inquiry over gain

Virginia high school admissions case could be legal follow

ADA: All diabetes patients should be screened for liver condition

After affirmative action ruling, medical educators look to 'holistic review'

STAT Summit: Meghan O’Rourke on making chronic illness visible

focus

Synthetic human embryos? Researchers say term is overblown

Brazil's Jair Bolsonaro is barred from running for office until 2030

Cassava Sciences’ Alzheimer’s clinical trials should be halted

Questions loom on AstraZeneca cancer drug as safety concerns ebb

Anger, defiance, fear over Supreme Court decision to block student loan forgiveness

Synthetic human embryos? Researchers say term is overblown

hotspot

Wikipedia

hotspot

hotspot